Disclosures for "SURWEY Study of Solriamfetol: Initiation, Titration, Safety, Efficacy, and Follow-up Experience for Patients with OSA in Germany"
-
Dr. Winter has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer AG. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Winter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bioprojet.
-
Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen, Idorsia, NLS Pharma. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia, Takeda. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Idorsia.
-
Heike Benes has nothing to disclose.
-
Lothar Burghaus has nothing to disclose.
-
Iresha Abeynayake has received personal compensation for serving as an employee of Axsome. Iresha Abeynayake has stock in Axsome.
-
Dr. Floam has received personal compensation for serving as an employee of Axsome Therapeutics.
-
-
Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
-
Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AOP Orphan . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioprojet . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AOP Orphan . Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet . Prof. Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz . Prof. Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Prof. Kallweit has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda . Prof. Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB .